# Relx PLC 14.4% potential upside indicated by JP Morgan Cazenove

- Link: https://www.directorstalkinterviews.com/relx-plc-14-4-potential-upside-indicated-by-jp-morgan-cazenove/4121185186
- Published: 2025-01-29T14:18:57+00:00
- Author: Charlotte Edwards

**[Relx PLC](https://www.directorstalkinterviews.com/ftse-company/relx-plc/rel.l)**
with ticker ([LON:REL](https://www.directorstalkinterviews.com/ftse-company/relx-plc/rel.l))
now has a potential upside of 14.4% according to [JP Morgan](https://www.directorstalkinterviews.com/company/news/funds)
Cazenove.
REL.LJP Morgan Cazenove set a target price of 4,550 GBX for the company,
which when compared to the Relx PLC share price of 3,977 GBX at opening today (29/
01/2025) indicates a potential upside of 14.4%. Trading has ranged between 3,218(
52 week low) and 3,998 (52 week high) with an average of 2,419,491 shares exchanging
hands daily. The market capitalisation at the time of writing is £91,980,220,000.
RELX PLC is a United Kingdom-based global provider of information-based analytics
and decision tools for professional and business customers. The Company operates
in four market segments: Risk; Scientific, Technical & Medical; Legal, and Exhibitions.
The Risk segment provides customers with information-based analytics and decision
tools that combine public and industry-specific content with advanced technology
and algorithms to assist them in evaluating and predicting risk and enhancing operational
efficiency. The Scientific, Technical & Medical segment provides information and
analytics that help institutions and professionals progress science, advance healthcare
and improve performance. The Legal segment provides legal, regulatory and business
information and analytics. The Exhibitions segment combines industry expertise with
data and digital tools to help customers connect face-to-face and digitally, learn
about markets, source products and complete transactions.

Share on: